Barrat FJ - Search Results

1

RNA recognition by human TLR8 can lead to autoimmune inflammation.

Guiducci C, Gong M, Cepika AM, Xu Z, Tripodo C, Bennett L, Crain C, Quartier P, Cush JJ, Pascual V, Coffman RL, Barrat FJ. Guiducci C, et al. Among authors: barrat fj. J Exp Med. 2013 Dec 16;210(13):2903-19. doi: 10.1084/jem.20131044. Epub 2013 Nov 25. J Exp Med. 2013. PMID: 24277153 Free PMC article.

2

Reclassification of plasmacytoid dendritic cells as innate lymphocytes is premature.

Reizis B, Idoyaga J, Dalod M, Barrat F, Naik S, Trinchieri G, Tussiwand R, Cella M, Colonna M. Reizis B, et al. Nat Rev Immunol. 2023 May;23(5):336-337. doi: 10.1038/s41577-023-00864-y. Nat Rev Immunol. 2023. PMID: 36959479 No abstract available.

3

Cutting edge: ectopic expression of the IL-12 receptor-beta 2 in developing and committed Th2 cells does not affect the production of IL-4 or induce the production of IFN-gamma.

Heath VL, Showe L, Crain C, Barrat FJ, Trinchieri G, O'Garra A. Heath VL, et al. Among authors: barrat fj. J Immunol. 2000 Mar 15;164(6):2861-5. doi: 10.4049/jimmunol.164.6.2861. J Immunol. 2000. PMID: 10706670

4

1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.

Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. Boonstra A, et al. Among authors: barrat fj. J Immunol. 2001 Nov 1;167(9):4974-80. doi: 10.4049/jimmunol.167.9.4974. J Immunol. 2001. PMID: 11673504

5

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O'Garra A. Barrat FJ, et al. J Exp Med. 2002 Mar 4;195(5):603-16. doi: 10.1084/jem.20011629. J Exp Med. 2002. PMID: 11877483 Free PMC article.

6

IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences.

Duramad O, Fearon KL, Chan JH, Kanzler H, Marshall JD, Coffman RL, Barrat FJ. Duramad O, et al. Among authors: barrat fj. Blood. 2003 Dec 15;102(13):4487-92. doi: 10.1182/blood-2003-07-2465. Epub 2003 Aug 28. Blood. 2003. PMID: 12946990 Free article.

7

Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation.

Duramad O, Fearon KL, Chang B, Chan JH, Gregorio J, Coffman RL, Barrat FJ. Duramad O, et al. Among authors: barrat fj. J Immunol. 2005 May 1;174(9):5193-200. doi: 10.4049/jimmunol.174.9.5193. J Immunol. 2005. PMID: 15843514

8

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.

Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL. Barrat FJ, et al. J Exp Med. 2005 Oct 17;202(8):1131-9. doi: 10.1084/jem.20050914. J Exp Med. 2005. PMID: 16230478 Free PMC article.

9

Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.

Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, Matray T, Lee KD, Coffman RL, Barrat FJ. Guiducci C, et al. Among authors: barrat fj. J Exp Med. 2006 Aug 7;203(8):1999-2008. doi: 10.1084/jem.20060401. Epub 2006 Jul 24. J Exp Med. 2006. PMID: 16864658 Free PMC article.

10

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.

Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Kanzler H, et al. Among authors: barrat fj. Nat Med. 2007 May;13(5):552-9. doi: 10.1038/nm1589. Nat Med. 2007. PMID: 17479101 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters